Iconic Labs PLC Restructuring Update
02 Février 2023 - 08:55AM
UK Regulatory (RNS & others)
TIDMICON
RNS Number : 7169O
Iconic Labs PLC
02 February 2023
Iconic Labs PLC
("Iconic" or the "Company")
Restructuring Update
Iconic Labs PLC (LSE:ICON), provides this restructuring update
following this first week after the trading suspension was
lifted.
Iconic thanks its shareholders for their patience as management
continues to stabilise the Company. Lifting the trading suspension
was a significant step forward for the Company and whilst the
Directors understand that shareholders are eager for news about the
future, potential acquisitions, and strategy, their current focus
is necessarily on completing the restructuring process.
Firstly, to fulfill its obligations under the Company Voluntary
Arrangement ("CVA"), Iconic still must make two cash payments of
GBP50,000 each for the months of February and March, and then a
final GBP15,000 payment for April.
The cash for these payments shall come from the GBP3 million
financing facility with European High Growth Opportunities
Securitization Fund ("EHGOSF") provided (i) the closing market
price of the shares for each of the ten consecutive trading days
falling immediately prior to the relevant closing date is at least
higher than 150% of the nominal value of Iconic's shares; and (ii)
the average daily value traded of Iconic's shares (excluding 5% of
the data points from the top and excluding 5% of the data points
from the bottom of the data set) for the 20 trading days
immediately prior to the applicable closing date is at least GBP
10,000.
EHGOSF provides this financing to Iconic through notes with
warrants attached that are then converted into shares. While this
leads to some dilution, the Company asks that shareholders
recognise that this financing does not lead to any corresponding
cash liability; meaning, Iconic does not owe cash to EHSOSF for
this financing. This is a valuable financing tool for a company in
Iconic's position striving to have clean books with no
liabilities.
Secondly, once those three payments have been made, Iconic must
then fulfill its final obligation under the CVA of issuing
1,674,130,609 shares to the unsecured creditors. Iconic reminds
shareholders that again, whilst this will lead to some dilution,
these unsecured creditors had cash claims against the Company.
Those claims have been cleared from Iconic's books and satisfied
with a 75% discount paid in shares.
Thirdly, secured creditor claims brought against Iconic of
roughly GBP4,200,000 were reduced to GBP750,000 to be satisfied
through the issue of convertible notes, and EHGOSF reduced its
historic claims against Iconic of GBP3,000,000 down to GBP750,000
to be satisfied through the issue of convertible notes. Again, this
will result in some dilution, but compared to the original sums
claimed against the Company, this is a significant result.
Finally, regarding potential acquisitions, Iconic has been in
early stage talks with various parties. However, given that the
trading suspension was only lifted last week, Iconic is only now
able to move beyond preliminary discussions with those parties. It
is anticipated that any acquisition that Iconic makes will most
likely be a reverse takeover under the Listing Rules. Further
updates on these discussions will be provided in due course.
Brad Taylor, CEO stated:
"Restructuring a company that was in the distressed position
that Iconic was in is a lengthy process. We have succeeded in
exiting administration and getting the trading suspension lifted,
two accomplishments that have rarely, if ever, been done before for
a main market LSE company. We continue the process of stabilising
the Company and discussing potential acquisitions with various
entities so that we can generate shareholder value."
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it
forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with
the Company's obligations under Article 17 of MAR.
For any further information or enquiries please contact:
ir@iconiclabs.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDDLLBBXLLEBBL
(END) Dow Jones Newswires
February 02, 2023 02:55 ET (07:55 GMT)
Widecells (LSE:WDC)
Graphique Historique de l'Action
De Mar 2023 à Mar 2023
Widecells (LSE:WDC)
Graphique Historique de l'Action
De Mar 2022 à Mar 2023